Thailand Pharmacy Retail Market Overview
According to SPER Market Research, the Thailand Pharmacy Retail Market is estimated to reach USD XX billion by 2032 with a CAGR of 2.36%.
Due to the nation's expanding need for healthcare goods and services, Thailand's retail pharmacy business is a flourishing sector of the economy. The Thai government has put in place regulations to expand access to healthcare and pharmaceutical items, which has increased the number of pharmacies around the nation. The market provides a variety of goods and services, including as prescription drugs, over-the-counter medicines, dietary supplements, and goods for the body and face.
The retail pharmacy market in Thailand mostly focuses on consumers. Consumers are increasingly looking for healthcare products and services as the population ages and healthcare awareness rises. From low-cost health and beauty products to high-end health and beauty products, the market offers a variety of goods to suit all demands and budgets. Also, people can now receive healthcare goods and services from the convenience of their homes thanks to the growth of e-commerce and online pharmacies.
Another significant target area in the Thai market is pharmacy retail chains. Retail companies are expanding their product and service offerings in response to the fiercer competition in an effort to draw and keep customers. In order to provide clients with a one-stop shop, many retail chains have expanded into other healthcare-related industries like clinics and diagnostic services. Pharmacy retail chains can now supply their consumers with a wider choice of services thanks to alliances with insurance companies and other healthcare organisations.
Impact of COVID-19 on the Thailand Pharmacy Retail Market
The retail pharmacy market in Thailand has been significantly impacted by the COVID-19 outbreak. In Thailand, there has been a considerable shift towards online pharmacy retail due to lockdowns and travel restrictions. The demand for e-commerce platforms has increased as consumers increasingly use online stores to buy prescription drugs and other healthcare items. As people look to strengthen their immune systems, the pandemic has also increased demand for health and wellness products like vitamins and supplements. Also, non-essential goods like cosmetics and personal care products have seen a decline in demand. To protect the wellbeing of their clients and employees, pharmacies have had to adjust to new rules and guidelines. To stop the virus from spreading, steps have been taken such social seclusion, improved cleanliness and sanitation, and contactless payment. The COVID-19 epidemic has to light the value of the Thai pharmacy retail market in supplying the populace with necessary medical supplies and services. The market will need to adjust to accommodate changing consumer demands as the epidemic spreads while continuing to place a high priority on the health and safety of both customers and employees.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Market Structure, By Product Categories, By Drugs, By Therapeutic Areas.
|
| Regions covered | Bangkok, Pattaya, Phuket, Others.
|
| Companies Covered | ArinCare, Bangkok Drugstore, Boots Retail, ChiiWii, CM Mediclinic, Doctor Anywhere, Doctor A-Z, Fascino, Health Up, Healthy Max, I-care, Lab Pharmacy, Matsumotokiyoshi, Ooca, P&F, Pure by Big C, Raksa, Save Drug, Tsuruha, Watsons.
|
Key Target Audience
- Pharmaceutical Manufacturing Companies
- Pharmacy Retail Companies
- Independent Pharmacies
- Industry Associations
- Government and Regulatory Bodies
- Telemedicine Companies
- Pharmaceutical Distributors & Wholesalers
Thailand Pharmacy Retail Market Segmentation:
1. By Market Structure:
2. By Product Categories:
- Medical Equipments
- Non-Pharmaceutical Products
- Over-The-Counter
- Prescribed Drugs
3. By Drugs:
4. By Therapeutic Areas:
- Antibiotic
- Anti-Infective
- Cardiovascular
- Gastro Intestinal
- Gynecology
- Neuro
- Pain /Analgesics
- Respiratory
- Vitamins / Minerals / Nutrients
- Others
5. By Region:
- Bangkok
- Pattaya
- Phuket
- Others
Key Topics Covered in the Report
- Thailand Pharmacy Retail Market Size (FY’2019-FY’2032)
- Overview of Thailand Pharmacy Retail Market
- Segmentation of Thailand Pharmacy Retail Market By Market Structure (Organized , Unorganized)
- Segmentation of Thailand Pharmacy Retail Market By Product Categories (Medical Equipments, Non-Pharmaceutical Products, Over-The-Counter, Prescribed Drugs)
- Segmentation of Thailand Pharmacy Retail Market By Drugs (Generics, Patented)
- Segmentation of Thailand Pharmacy Retail Market By Therapeutic Areas (Antibiotic, Anti-Infective, Cardiovascular, Gastro Intestinal, Gynecology, Neuro, Pain /Analgesics, Respiratory, Vitamins / Minerals / Nutrients, Others)
- Statistical Snap of Thailand Pharmacy Retail Market
- Growth Analysis of Thailand Pharmacy Retail Market
- Problems and Challenges in Thailand Pharmacy Retail Market
- Competitive Landscape in the Thailand Pharmacy Retail Market
- Impact of COVID-19 and Demonetization on Thailand Pharmacy Retail Market
- Details on Recent Investment in Thailand Pharmacy Retail Market
- Competitive Analysis of Thailand Pharmacy Retail Market
- Key Players in the Thailand Pharmacy Retail Market
- SWOT Analysis of Thailand Pharmacy Retail Market
- Thailand Pharmacy Retail Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Thailand Pharmacy Retail Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Thailand Pharmacy Retail Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Thailand Pharmacy Retail Market
7. Thailand Pharmacy Retail Market, By Market Structure, 2019-2032 (USD Million)
7.1 Organized
7.2 Unorganized
8. Thailand Pharmacy Retail Market, By Product Categories, 2019-2032 (USD Million)
8.1 Medical Equipments
8.2 Non-Pharmaceutical Products
8.3 Over-The-Counter
8.4 Prescribed Drugs
9. Thailand Pharmacy Retail Market, By Drugs, 2019-2032 (USD Million)
9.1 Generics
9.2 Patented
10. Thailand Pharmacy Retail Market, By Therapeutic Areas, 2019-2032 (USD Million)
10.1 Antibiotic
10.2 Anti-Infective
10.3 Cardiovascular
10.4 Gastro Intestinal
10.5 Gynecology
10.6 Neuro
10.7 Pain /Analgesics
10.8 Respiratory
10.9 Vitamins / Minerals / Nutrients
10.10 Others
11. Thailand Pharmacy Retail Market, By Region, 2019-2032 (USD Million)
11.1 Thailand Pharmacy Retail Size and Market Share by Region (2019-2025)
11.2 Thailand Pharmacy Retail Size and Market Share by Region (2026-2032)
11.3 Bangkok
11.4 Pattaya
11.5 Phuket
11.6 Others
12. Company Profiles
12.1. ArinCare
12.1.1 Company details
12.1.2 Financial outlook
12.1.3 Product summary
12.1.4 Recent developments
12.2. Bangkok Drugstore
12.2.1 Company details
12.2.2 Financial outlook
12.2.3 Product summary
12.2.4 Recent developments
12.3. Boots Retail
12.3.1 Company details
12.3.2 Financial outlook
12.3.3 Product summary
12.3.4 Recent developments
12.4. ChiiWii
12.4.1 Company details
12.4.2 Financial outlook
12.4.3 Product summary
12.4.4 Recent developments
12.5. CM Mediclinic
12.5.1 Company details
12.5.2 Financial outlook
12.5.3 Product summary
12.5.4 Recent developments
12.6. Doctor Anywhere
12.6.1 Company details
12.6.2 Financial outlook
12.6.3 Product summary
12.6.4 Recent developments
12.7. Doctor A-Z
12.7.1 Company details
12.7.2 Financial outlook
12.7.3 Product summary
12.7.4 Recent developments
12.8. Fascino
12.8.1 Company details
12.8.2 Financial outlook
12.8.3 Product summary
12.8.4 Recent developments
12.9. Health Up
12.9.1 Company details
12.9.2 Financial outlook
12.9.3 Product summary
12.9.4 Recent developments
12.10. Healthy Max
12.10.1 Company details
12.10.2 Financial outlook
12.10.3 Product summary
12.10.4 Recent developments
12.11. I-care
12.11.1 Company details
12.11.2 Financial outlook
12.11.3 Product summary
12.11.4 Recent developments
12.12. Lab Pharmacy
12.12.1 Company details
12.12.2 Financial outlook
12.12.3 Product summary
12.12.4 Recent developments
12.13. Matsumotokiyoshi
12.13.1 Company details
12.13.2 Financial outlook
12.13.3 Product summary
12.13.4 Recent developments
12.14. Ooca
12.14.1 Company details
12.14.2 Financial outlook
12.14.3 Product summary
12.14.4 Recent developments
12.15. P&F
12.15.1 Company details
12.15.2 Financial outlook
12.15.3 Product summary
12.15.4 Recent developments
12.16. Pure by Big C
12.16.1 Company details
12.16.2 Financial outlook
12.16.3 Product summary
12.16.4 Recent developments
12.17. Raksa
12.17.1 Company details
12.17.2 Financial outlook
12.17.3 Product summary
12.17.4 Recent developments
12.18. Save Drug
12.18.1 Company details
12.18.2 Financial outlook
12.18.3 Product summary
12.18.4 Recent developments
12.19. Tsuruha
12.19.1 Company details
12.19.2 Financial outlook
12.19.3 Product summary
12.19.4 Recent developments
12.20. Watsons
12.20.1 Company details
12.20.2 Financial outlook
12.20.3 Product summary
12.20.4 Recent developments
13. List of Abbreviations
14. Reference Links
15. Conclusion
16. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
